Russia Sets First National Standard for 3D Bioprinting of Organs

Russia has introduced its first national standard for 3D bioprinting of tissues and organs. Known as GOST, the new framework sets clear rules for developing and applying bioprinting technologies across the country. Until now, research in this field had progressed in isolated efforts without unified guidelines. The standard was created by researchers at the National University of Science and Technology MISIS (NUST MISIS), working alongside industry experts and biotechnology firms. Consultations involved professionals from science, medicine, and commercial sectors to ensure broad relevance. Its final version incorporates international best practices, though specific references to foreign organisations or prior GOST standards in this area were not disclosed.

The new GOST establishes core principles, terminology, and safety requirements for bioprinting. Its goal is to guarantee consistent, reproducible results while smoothing the transition from lab experiments to real-world medical and industrial applications. Previously, Russia's bioprinting advancements lacked coordination, with institutions and companies operating independently. Analysts suggest the standard will boost Russia's standing in biomedical innovation. It is also expected to encourage closer partnerships between academic researchers and private enterprises. The regulations will officially come into force on September 1, 2026.

The adoption of this standard marks a shift toward structured, large-scale development in Russia's bioprinting sector. By setting uniform technical and safety benchmarks, it aims to accelerate progress from research to practical use. The framework will apply nationwide once implemented in 2026.